Anti-IYD1/ IYD/ C6orf71 monoclonal antibody

Anti-IYD1/ IYD/ C6orf71 antibody for FACS & in-vivo assay

Target products collectionGo to IYD/IYD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0645-Ab-1/ GM-Tg-hg-MP0645-Ab-2Anti-Human IYD monoclonal antibodyHuman
GM-Tg-rg-MP0645-Ab-1/ GM-Tg-rg-MP0645-Ab-2Anti-Rat IYD monoclonal antibodyRat
GM-Tg-mg-MP0645-Ab-1/ GM-Tg-mg-MP0645-Ab-2Anti-Mouse IYD monoclonal antibodyMouse
GM-Tg-cynog-MP0645-Ab-1/ GM-Tg-cynog-MP0645-Ab-2Anti-Cynomolgus/ Rhesus macaque IYD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0645-Ab-1/ GM-Tg-felg-MP0645-Ab-2Anti-Feline IYD monoclonal antibodyFeline
GM-Tg-cang-MP0645-Ab-1/ GM-Tg-cang-MP0645-Ab-2Anti-Canine IYD monoclonal antibodyCanine
GM-Tg-bovg-MP0645-Ab-1/ GM-Tg-bovg-MP0645-Ab-2Anti-Bovine IYD monoclonal antibodyBovine
GM-Tg-equg-MP0645-Ab-1/ GM-Tg-equg-MP0645-Ab-2Anti-Equine IYD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0645-Ab-1/ GM-Tg-hg-MP0645-Ab-2; GM-Tg-rg-MP0645-Ab-1/ GM-Tg-rg-MP0645-Ab-2;
GM-Tg-mg-MP0645-Ab-1/ GM-Tg-mg-MP0645-Ab-2; GM-Tg-cynog-MP0645-Ab-1/ GM-Tg-cynog-MP0645-Ab-2;
GM-Tg-felg-MP0645-Ab-1/ GM-Tg-felg-MP0645-Ab-2; GM-Tg-cang-MP0645-Ab-1/ GM-Tg-cang-MP0645-Ab-2;
GM-Tg-bovg-MP0645-Ab-1/ GM-Tg-bovg-MP0645-Ab-2; GM-Tg-equg-MP0645-Ab-1/ GM-Tg-equg-MP0645-Ab-2
Products NameAnti-IYD monoclonal antibody
Formatmab
Target NameIYD
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IYD benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species IYD1/ IYD/ C6orf71 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0645
    Target NameIYD
    Gene ID389434,70337,308129,705471,476244,101100136,534110,100147582
    Gene Symbol and Synonyms0610009A07Rik,C6orf71,DEHAL1,IYD,IYD-1,RGD1309288,TDH4
    Uniprot AccessionQ6PHW0,Q5BK17
    Uniprot Entry NameIYD1_HUMAN,IYD1_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000009765
    Target ClassificationN/A

    The target: IYD, gene name: IYD, also named as C6orf71, DEHAL1-1, TDH4, IYD. This gene encodes an enzyme that catalyzes the oxidative NADPH-dependent deiodination of mono- and diiodotyrosine, which are the halogenated byproducts of thyroid hormone production. The N-terminus of the protein functions as a membrane anchor. Mutations in this gene cause congenital hypothyroidism due to dyshormonogenesis type 4, which is also referred to as deiodinase deficiency, or iodotyrosine dehalogenase deficiency, or thyroid hormonogenesis type 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.